MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,340 | +0.5% | 1,500,000 | -16.7% | 2.15% | +1.7% |
| Q2 2023 | $65,034 | +24.9% | 1,800,000 | +28.6% | 2.12% | +32.3% |
| Q1 2023 | $52,052 | -17.9% | 1,400,000 | 0.0% | 1.60% | -26.4% |
| Q4 2022 | $63,434 | -100.0% | 1,400,000 | -30.0% | 2.18% | -49.1% |
| Q3 2022 | $139,680,000 | +220.1% | 2,000,000 | +207.7% | 4.28% | +125.9% |
| Q2 2022 | $43,635,000 | -55.8% | 650,000 | -45.8% | 1.89% | -47.0% |
| Q1 2022 | $98,664,000 | +17.0% | 1,200,000 | +108.7% | 3.57% | +23.1% |
| Q4 2021 | $84,347,000 | +6.0% | 575,000 | +27.8% | 2.90% | +18.3% |
| Q3 2021 | $79,610,000 | +23.2% | 450,000 | +12.5% | 2.45% | +12.6% |
| Q2 2021 | $64,612,000 | +201.7% | 400,000 | +220.0% | 2.18% | +196.2% |
| Q1 2021 | $21,413,000 | – | 125,000 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |